Author
D. Schwartz
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2016-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 14 mutual co-author links5 papers
Recent·Most cited
Optimal dormancy strategies in fluctuating environments given delays in phenotypic switching
A. Magalie, D. Schwartz, J. T. Lennon, J. Weitz
This study develops a dynamic model to analyze optimal dormancy strategies in fluctuating environments, considering time delays in phenotypic switching and environmental correlations.
bioRxiv · Oct 25, 2022Ecology
RadGenNets: Deep Learning-Based Radiogenomics Model For Gene Mutation Prediction In Lung Cancer
S. Tripathi, A. I. Augustin, E. J. Moyer, A. Zavalny, S. Dheer, R. Sukumaran, D. Schwartz, B. Gorski, F. Dako, E. Kim
The paper develops a deep learning model that predicts gene mutations in NSCLC patients using CT scans and clinical-genomics data, achieving 94% AUC.
bioRxiv · Apr 13, 2022Cancer Biology
An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19
R. McGregor, D. Chauss, T. Freiwald, B. Yan, L. Wang, E. Nova-Lamperti, Z. Zhang, H. Teague, E. West, J. Bibby, A. Kelly, A. Malik, A. Freeman, D. Schwartz, D. Portilla, , B. Afzali
This study identifies a Vitamin D-driven mechanism that suppresses excessive Th1 responses in COVID-19, suggesting potential therapeutic use of Vitamin D analogs.
bioRxiv · Jul 18, 2020 · PreprintImmunology
Cushing’s Syndrome mutant PKAL205R exhibits altered substrate specificity
J. M. Lubner, K. L. Dodge-Kafka, C. R. Carlson, G. M. Church, M. F. Chou, D. Schwartz
This study investigates how the PKAL205R mutation in Cushing’s Syndrome alters PKA substrate specificity using a proteomic peptide library approach.
bioRxiv · Dec 5, 2016Biochemistry